Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia

Clinical trial NCT02914977 · COMPLETED

Trial details

NCT number: NCT02914977
Sponsor: Tara Lin
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphocytic Leukemia Acute Myeloid Leukemia

Start date: 2016-11-01
Primary completion: 2019-04-03
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.